Satipharm begins clinical trial of CBD capsules for treating menopause
  Author: Saipriya Iyer

Cannabis was prior considered to possess various medicinal benefits for treating diseases. However, after years of res...

Read More
Recardio announces conclusion of interim analysis of Phase 2 in AMI
  Author: Pankaj Singh

  The study of combination of dutogliptin and filgrastim involved approximately 120 patient enrollments. ...

Read More
CytRx publishes results from Arimoclomol Phase 2 trial for sIBM
  Author: Saipriya Iyer

CytRx Corporation, a biopharmaceutical firm that specializes principally in neurodegenerative and oncology diseases, r...

Read More
U.S. FDA gives nod to Inovio to start Phase ½ trial for INO-3107
  Author: Pankaj Singh

Inovio Pharmaceuticals, Inc. has received green signal from the U.S. FDA to assess its Phase ½ trial for DNA me...

Read More
FDA grants Priority Review of NDA for Astex's oral C-DEC
  Author: Saipriya Iyer

Astex Pharmaceuticals, Inc., a subsidiary of Otsuka Pharmaceutical Co. Ltd., announced that it has received Priority Review for its NDA for oral C-...

Read More
Moderna enrolls Phase 2 trial to test mRNA-1647 immunogenicity & safety
  Author: Pankaj Singh

Moderna, Inc., a biotechnology company pioneering in drug discovery and development based on mRNA, has recently announ...

Read More
Sanofi’s BTK inhibitor meets primary endpoint in Phase 2b to treat MS
  Author: Saipriya Iyer

MS (multiple sclerosis) is a serious disease that affects about 1.2 million people across the U.S. and Europe. The ail...

Read More
MEDISCA issues U.S. Patent 10,420,705 for planetary mixers adapter
  Author: Pankaj Singh

MEDISCA Inc., a global leader in the pharmaceutical compounding industry, has recently announced the issuance of U.S. ...

Read More
Mesoblast submits BLA to get Ryoncil™ FDA-approved for treating SRaGVHD
  Author: Pankaj Singh

Mesoblast Limited has recently announced the submission of the completed BLA (Biologics License Application) to the U.S....

Read More
Corvus Pharmaceuticals unveils updated data from Phase 1/1b trial
  Author: Saipriya Iyer

Corvus Pharmaceuticals, Inc., a clinical-stage science driven biopharmaceutical firm focusing on the commercialization and development of precisely...

Read More
Pulse Biosciences to present data on NPS technology for treating nBCC
  Author: Pankaj Singh

Pulse Biosciences Inc., a bioelectric medicine company, has reportedly announced that it will be presenting its scient...

Read More
Timber Pharmaceuticals and BioPharmX Corp. inks merger agreement
  Author: Saipriya Iyer

A specialty pharmaceutical company, BioPharmX Corporation and a privately held biopharmaceutical company, Timber ...

Read More
Nestlé acquires Allergan’s Zenpep to expand medical nutrition business
  Author: Saipriya Iyer

Nestle, a Swiss food and beverage giant, has recently expanded its medical nutrition business by entering an asset purch...

Read More
Epizyme gets FDA approval for TAZVERIK™ to treat epithelioid sarcoma
  Author: Pankaj Singh

Epizyme, Inc., a renowned biopharmaceutical company developing new epigenetic therapies, has reportedly announced that...

Read More
New Medtronic Micra AV pacemaker receives approval from the U.S. FDA
  Author: Saipriya Iyer

Medtronic plc, a renowned US-based medical device company, reportedly announced that its Micra AV pacemaker has receiv...

Read More
Eli Lilly and Company to build a manufacturing unit in North Carolina
  Author: Pankaj Singh

Global pharmaceutical firm, Eli Lilly and Company has recently revealed plans to create over 460 new jobs by investing...

Read More
Health Canada grants two DIN to new Tetra Bio-pharma OTC products
  Author: Saipriya Iyer

Tetra Bio-pharma, a renowned Canadian biopharmaceutical company, reportedly announced that Health Canada, the regulato...

Read More
Innate Pharma announces regulatory updates for TELLOMAK Phase II study
  Author: Saipriya Iyer

Innate Pharma SA, a commercial biopharmaceutical firm involved in the development of immunotherapy drug candidates to ...

Read More
Teledentistry pioneer, Smile Direct Club plans to expand in Hong Kong
  Author: Pankaj Singh

SmileDirectClub, a pioneer in teledentistry recently announced plans to expand in Asia, by acquainting Hongkonger...

Read More
Chembio announces update on the FDA submission of DDP HIV-syphilis
  Author: Pankaj Singh

  The developer and marketer of rapid diagnostic tests anticipates the FDA approval of its...

Read More
AstraZeneca and Merck attain FDA nod for a pancreatic cancer drug
  Author: Saipriya Iyer

The drug, dubbed Lynparza, is currently approved in almost 65 countries for the maintenance treatment of plati...

Read More
FDA approves AVITA Medical’s IDE application to assess RECELL system
  Author: Pankaj Singh

AVITA Medical Limited, a regenerative medicine firm addressing unmet medical needs in therapeutic skin restoration, ha...

Read More
Patient screening of Innovation Pharmaceuticals’ phase 1 trial in Jan
  Author: Pankaj Singh

Innovation pharmaceuticals is gearing for the roll out of patient screening for phase 1 trial in January that will app...

Read More
OBI Pharma bags FDA Orphan Drug Designation for cancer drug, OBI-999
  Author: Saipriya Iyer

Taiwan-based biopharmaceutical firm, OBI Pharma, Inc. has reportedly been granted the Orphan Drug Designation by ...

Read More
FDA authorizes Allergan’s oral medication Ubrelvy to treat migraine
  Author: Pankaj Singh

FDA authorizes Allergan’s oral medication Ubrelvy to treat migraine ...

Read More
Allergan receives approval for its migraine drug Ubrelvy from FDA
  Author: Pankaj Singh

Allergan, a renowned multinational biopharmaceutical company, has been awarded approval for its oral CGRP (calcitonin ...

Read More
Exelixis partners with Roche to evaluate advanced solid tumor therapies
  Author: Saipriya Iyer

Exelixis Inc., a California-based drug discovery firm that focuses on discovering, developing and then commercializing d...

Read More
MODAG starts first-in-human Phase 1 clinical trial for Anle138b
  Author: Pankaj Singh

MODAG has announced the start of clinical trial and recruitment for a first-in-human Phase 1 study of Anle 138b in hea...

Read More
The Lancet publishes Phase 3 trial results of FINTEPLA® of Zogenix
  Author: Saipriya Iyer

Zogenix, a renowned US-based pharmaceutical company, reportedly announced that The Lancet, a renowned medical journal,...

Read More
Walgreens Boots Alliance inks deal with McKesson Corporation
  Author: Saipriya Iyer

Walgreens Boots Alliance, an American holding company headquartered in Illinois inked a deal with Mckesson Corporation...

Read More
Amphivena announces initial data from Phase 1 study of AMV564
  Author: Saipriya Iyer

Amphivena Therapeutics, Inc., a clinical stage immuno-oncology firm developing T cell engager therapies for cancer, ha...

Read More
Sanofi to acquire biotechnology firm Synthorx for $2.5 billion
  Author: Saipriya Iyer

Sanofi, a renowned France based multinational pharmaceutical company, reportedly announced that it would be acquiring ...

Read More
GE Healthcare Life Sciences & ASLS unite to advance 3D biofabrication
  Author: Pankaj Singh

  The alliance is aimed at personalizing regenerative tissue manufacturing processes ...

Read More
uniQure updates follow up-data from hemophilia B therapy trials
  Author: Saipriya Iyer

uniQure N.V, a renowned gene therapy firm that advances evolving therapies for all the patients who have severe medica...

Read More
Hummingbird Bio secures $19M to expand antibody therapeutics portfolio
  Author: Pankaj Singh

Hummingbird Bioscience, an advanced biotherapeutics company, recently announced it has raised USD 19 million in a Seri...

Read More
Acadia announces positive results of Phase 3 trial to treat psychosis
  Author: Pankaj Singh

Acadia Pharmaceuticals, a renowned US-based biopharmaceutical company dedicated to the development of treatments for c...

Read More
Veracyte inks deal with NanoString for nCounter® diagnostic platform
  Author: Saipriya Iyer

San-Francisco based leading diagnostics company Veracyte has recently announced a definitive agreement with NanoString...

Read More
Senseonics’ Eversense® obtains non-adjunctive labeling claim in U.S.
  Author: Pankaj Singh

Senseonics Holdings, Inc., a US-based medical device startup company recently announced that users of its Eversen...

Read More
Astellas Pharma inks a $3 Bln deal to acquire Audentes Therapeutics
  Author: Pankaj Singh

Japanese pharmaceutical company, Astellas Pharma Inc. has reportedly entered into a definitive agreement to acquire bi...

Read More
FDA accepts NDA for Pemigatinib, announces Innovent Biologics
  Author: Pankaj Singh

  Pemigatinib has been granted priority review by the FDA ...

Read More
Jubilant Biosys to begin expansion of its drug discovery services
  Author: Saipriya Iyer

Jubilant Biosys, a Jubilant Lifesciences Limited subsidiary based in Bengaluru, recently announced it will be starting...

Read More
Emerald Healths Pure Sunfarms signs cannabis supply deal with AGLC
  Author: Saipriya Iyer

Emerald Health Therapeutics, a renowned Canada-based licensed medical cannabis producer, reportedly announced that its 50% owned subsidiary, Pure S...

Read More
Bio-Path Holdings finalizes safety testing in Phase 2 trial targeting AML
  Author: Pankaj Singh

Bio-Path Holdings Inc., a biotechnology company developing novel therapeutics, has reportedly announced the successful...

Read More
Intuitive’s E-100 generator and SynchroSeal gets the FDA clearance
  Author: Pankaj Singh

Intuitive, a US-based developer, manufacturer, and marketer of the robotic products designed to improve clinical resul...

Read More
Ferring and Blackstone jointly invest in a new bladder cancer therapy
  Author: Pankaj Singh

Private investment firm, Blackstone Life Sciences and Ferring Pharmaceuticals recently announced joint investment of m...

Read More
AVITA Medical & Gates Center unite to explore spray-on skin treatment
  Author: Pankaj Singh

AVITA Medical and Gates Center for Regenerative Medicine have reportedly inked a Sponsored Research Agreement or SRA t...

Read More
Anelixis announces the conclusion of AT-1501 Phase 1 clinical trial
  Author: Saipriya Iyer

Anelixis Therapeutics has reportedly concluded its testing of an investigational antibody, AT-1501, in a Phase 1 clini...

Read More
European Commission approves Merck KEYTRUDA as a HNSCC treatment
  Author: Saipriya Iyer

Merck, a renowned American pharmaceutical firm and one of the largest pharmaceutical companies in the world reportedly...

Read More
Early data from first human CRISPR trials reveals promising results
  Author: Pankaj Singh

Vertex Pharmaceuticals and CRISPR Therapeutics have recently revealed early data from their joint trials to test CRISP...

Read More
Triple Gene releases Phase 1 study data for INXN-4001 in heart failure
  Author: Saipriya Iyer

Triple Gene LLC- a U.S. based cardiovascular gene therapy enterprise recently furnished preliminary data from its Phas...

Read More
Novartis’ trial of Entresto reveals potential beyond HFrEF treatment
  Author: Pankaj Singh

Swiss pharma-company Novartis has reportedly revealed subgroup results from its global PARAGON-HF Phase III study. The...

Read More
Stanford medicine releases its research on Apple Heart watches
  Author: Pankaj Singh

The study comprised enrollment of over 400,000 people, making it one of the biggest research efforts....

Read More
Daiichi Sankyo announces positive results from Phase 3 pivotal trial
  Author: Saipriya Iyer

Daiichi Sankyo Company, Limited (hereafter Daiichi Sankyo), today made a breakthrough announcement stating that the ma...

Read More
WeChat Pay & Alipay allow overseas users to use international cards
  Author: Pankaj Singh

On the foundation of the popular digital payment services, China is moving towards a cashless economy. In a bid to off...

Read More
CANbridge Pharmaceuticals receives registration approval for NERLYNX®
  Author: Saipriya Iyer

Puma Biotechnology, Inc. has reportedly announced that its licensing partner CANbridge Pharmaceuticals Inc., based in ...

Read More
Melanoma Research Alliance raises $20M for new research program
  Author: Saipriya Iyer

Of late, several medical firms and associations are carrying out novel research programs and funding to support their ...

Read More
Savonix and Boston University to digitally gather cognitive health data
  Author: Saipriya Iyer

Savonix Inc.- a U.S. based company dedicated towards providing digital tests for cognitive health and Boston University- a global leading school fo...

Read More
China gives nod to new seaweed-based Alzheimer’s drug Oligomannate
  Author: Saipriya Iyer

The Chinese government has reportedly approved world’s first drug in 20 years for treating Alzheimer’s dis...

Read More
Knight & TherapeuticsMD amid filing a NDS for Joyesta™ in Canada
  Author: Pankaj Singh

Knight Therapeutics Inc., a pharmaceutical company based in Canada, had last year entered a ...

Read More
Themis Bioscience, CEPI initiate Phase 1 study for Lassa Fever vaccine
  Author: Pankaj Singh

Lassa fever is a severe viral hemorrhagic illness which usually occurs due to human exposure to infected food or house...

Read More
Mirati Therapeutics reveals Phase ½ results of KRAS inhibitor therapy
  Author: Paroma Bhattacharya

Mirati Therapeutics, an oncology company that engages in the development of targeted therapies, recently released its ...

Read More
Nature Tech Corp partners with Aldevron for gene therapy manufacturing
  Author: Paroma Bhattacharya

The global cell and gene therapy sector is expected to witness a thriving period of growth over the forthcoming years....

Read More
Genentech IMbrave150 study meets coprimary endpoints for HCC treatment
  Author: Paroma Bhattacharya

With growing occurrence of liver cancer cases across the globe, the need to find a solution to the ailment is rising s...

Read More
Vertex announces reimbursement of ORKAMBI and SYMDEKO in Australia
  Author: Pankaj Singh

Vertex Pharmaceuticals Inc. is a global biopharmaceutical company that is relentless in striving for medical excellenc...

Read More
Exicure reveals positive data from XCUR17 clinical trial for Psoriasis
  Author: Paroma Bhattacharya

Clinical trials play a vital role in developing new treatments that could immensely improve a person’s living. T...

Read More
Principia Biopharma reveals data from Phase 1/2 trial targeting ITP
  Author: Paroma Bhattacharya

Immune thrombocytopenia (ITP) is a type of blood abnormality that creates a shortage of blood cell fragments know...

Read More
Incyte unveils positive results from Phase 2 ruxolitinib cream study
  Author: Pankaj Singh

Vitiligo is a prominent skin diseases prevalent across the world that causes skin color loss. The disease is increasin...

Read More
ProQR reveals positive results from Phase 1/2 trial of Sepofarsen
  Author: Paroma Bhattacharya

Leber congenital amaurosis (LCA) is a very rare eye condition that can be seen in newborn babies. Currently, the ...

Read More
FDA approves Swiss dermatological company Galderma’s AKLIEF acne cream
  Author: Saipriya Iyer

Skin care is one of the fastest growing concerns of the modern generation and acne is the foremost issue many face in ...

Read More
Bavarian Nordic begins Phase 1 clinical trial of MVA-BN® WEV vaccine
  Author: Paroma Bhattacharya

The trial will reportedly examine the safety, tolerability and immunogenicity of MVA-BN WEV ...

Read More
Illumina inks a long-term NGS deal with Dutch company Qiagen
  Author: Pankaj Singh

The pharmaceutical industry is responsible for treating some of the most critical health issues. The sector produces, ...

Read More
HMS invests $7.5Mn in digital medication management firm MedAdvisor
  Author: Paroma Bhattacharya

Medication adherence or taking medications correctly and on time is one of the most important parts of any treatment. ...

Read More
Graybug Vision commences Phase 2b Clinical study to target wet AMD
  Author: Pankaj Singh

Macular degeneration is the leading cause of irreversible, serious vision loss that occurs when a section of...

Read More
Servier buys PIXUVRI Non-Hodgkin lymphoma therapy from CTI BioPharma
  Author: Saipriya Iyer

A substantial rise in occurrence of cancer cases is being witnessed across the globe lately. Various global pharmaceutical firms are increasingly w...

Read More
Merck reveals positive results from KEYTRUDA® Plus Phase 3 trial
  Author: Pankaj Singh

Breast cancer is initiated when genes regulating cell growth mutate. These mutations allows the cells to divide and mu...

Read More